ClinicalTrials.gg
Sign In

Hyperlactatemia clinical trials

The registry lists 50 studies for Hyperlactatemia across more than 10 countries. 7 are recruiting or about to start. 26 of them are mainly about Hyperlactatemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-07-16.

Get an email when these change. Save the Hyperlactatemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Status unknown
12
Not yet recruiting
4
Recruiting
3
Withdrawn
1
Terminated
1

Phase

Phase 2
5
Phase 4
3
Early Phase 1
2
Phase 1
1
Phase 3
1

Where

United States
7
China
6
France
6
Denmark
5
Turkey
5
Chile
2

Who runs them

University of Aarhus (3) · Pontificia Universidad Catolica de Chile (2) · Rigshospitalet, Denmark (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Central Hospital, Nancy, France (1) · Arrowhead Regional Medical Center (1) · Lindenwood University (1) · Erasmus Medical Center (1)

What is being tested here

Drugs under test in Hyperlactatemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dobutamine101
Metformin003
Thiamine002
Sodium Lactate002
Ascorbic Acid001
Glycerol001
Ringer's Lactate001
Tranexamic Acid001
Protease Inhibitor Formulation LB1148001

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 3 Hyperlactatemia studies recruiting now, 0 (0%) set no upper age limit and 1 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 1 (33%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
182 (67%)2 (67%)
302 (67%)2 (67%)
402 (67%)3 (100%)
502 (67%)3 (100%)
652 (67%)3 (100%)
751 (33%)2 (67%)
851 (33%)1 (33%)

Across all 50 studies, recruiting or not: 36% stop at 75 or younger and 32% at 65; 14% take children; 0% are for women only and 16% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperlactatemia studies take

Of 17 interventional studies with no phase under Hyperlactatemia, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase8 mo3–12 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 50. search them.